Controlled-release approaches towards the chemotherapy of tuberculosis

References

• World Health Orgnization (WHO)Report 2011Global TB control Available at http://www.who.int/tb/publications/global_report/en/
   Google Scholar
• RussellDGBarryCE3rdFlynnJATuberculosis: what we don’t know can, and does, hurt usScience2010328598085285620466922
   PubMed Web of Science ®Google Scholar
• ChanEDIsemanMDMultidrug-resistant and extensively drug-resistant tuberculosis: a reviewCurr Opin Infect Dis200821658759518978526
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)XDR-TB: Extensively Drug- resistant Tuberculosis March 2007GenevaWHO2007 Available from: http://www.who.int/entity/tb/challenges/xdr/news_mar07.pdfAccessed August 1, 2012
   Google Scholar
• DaviesPDDrug resistant tuberculosisJ R Soc Med6200194626126311387411
   PubMed Web of Science ®Google Scholar
• RyanKJRayCGSherris Medical Microbiology: An Introduction to Infectious Diseases4th edNew York, NYMcGraw-Hill2004
   Google Scholar
• FerrariGLangenHNaitoMPietersJA coat protein on phagosomes involved in the intracellular survival of mycobacteriaCell199997443544710338208
   PubMed Web of Science ®Google Scholar
• MeenaLSRajaniSurvival mechanisms of pathogenic Mycobacterium tuberculosis H37RvFEBS J2010277112416242720553485
   PubMed Web of Science ®Google Scholar
• MoulderJWComparative biology of intracellular parasitismMicrobiol Rev19854932983373900672
   PubMedGoogle Scholar
• GordonAHHartPAYoungMRAmmonia inhibits phagosomeslysosome fusion in macrophagesNature1980286576879816993961
   PubMed Web of Science ®Google Scholar
• CrowleAJDahlRRossEMayMHEvidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidicInfect Immun1991595182318311902198
   PubMed Web of Science ®Google Scholar
• Sturgill-KoszyckiSSchlesingerPHChakrabortyPLack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPaseScience199426351476786818303277
   PubMed Web of Science ®Google Scholar
• YuanYLeeREBesraGSBelisleJTBarryCE3rdIdentification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosisProc Natl Acad Sci U S A19959214663066347604045
   PubMed Web of Science ®Google Scholar
• FalkRRandolphTWMeyerJDKellyRMManningMCControlled release of ionic compounds from poly (L-lactide) microspheres produced by precipitation with a compressed antisolventJ Control Release19974417785
   Web of Science ®Google Scholar
• PandeyRSharmaAZahoorASharmaSKhullerGKPrasadBPoly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosisJ Antimicrob Chemother200352698198614613962
   PubMed Web of Science ®Google Scholar
• WHOGlobal Tuberculosis Control: Surveillance, Planning, FinancingWHO report WHO/HTM/TB/2005.349GenevaWHO2005 Available from: http://library.cphs.chula.ac.th/Ebooks/AnnualReport/WHOreport/WHOREPORT2005.pdfAccessed August 1, 2012
   Google Scholar
• Fourth annual meeting of the Stop TB Working Group onDOTS-Plus for MDR-TBParis, FranceOctober 27–28, 2003 http://whqlibdoc.who.int/hq/2004/WHO_HTM_TB_2004.341.pdf
   Google Scholar
• ZaleskisRThe side-effects of TB therapyBreathe2005215
   Google Scholar
• PrabakaranDSinghPJaganathanKVyasSPOsmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugsJ Control Release200495223924814980772
   PubMed Web of Science ®Google Scholar
• SmithJPNanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosisYale J Biol Med201184436136922180674
   PubMedGoogle Scholar
• SosnikACarcabosoAMGlisoniRJMorettonMAChiappettaDANew old challenges in tuberculosis: potentially effective nanotechnologies in drug deliveryAdv Drug Deliv Rev2010624–554755919914315
   PubMed Web of Science ®Google Scholar
• ZhangLPornpattananangkuDHuCMHuangCMDevelopment of nanoparticles for antimicrobial drug deliveryCurr Med Chem201017658559420015030
   PubMed Web of Science ®Google Scholar
• PandeyRKhullerGAntitubercular inhaled therapy: opportunities, progress and challengesJ Antimicrob Chemother200555443043515761077
   PubMed Web of Science ®Google Scholar
• FuJFiegelJKraulandEHanesJNew polymeric carriers for controlled drug delivery following inhalation or injectionBiomaterials200223224425443312219833
   PubMed Web of Science ®Google Scholar
• BatyckyRPHanesJLangerREdwardsDAA theoretical model of erosion and macromolecular drug release from biodegrading microspheresJ Pharm Sci19978612146414779423163
   PubMed Web of Science ®Google Scholar
• MaderKGallezBLiuKJSwartzHMNon-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopyBiomaterials19961744574618938242
   PubMed Web of Science ®Google Scholar
• ShiehLTamadaJChenIPangJDombALangerRErosion of a new family of biodegradable polyanhydridesJ Biomed Mater Res19942812146514757876286
   PubMed Web of Science ®Google Scholar
• VisserJVan der Waals and other cohesive forces affecting powder fluidizationPowder Technol1989581110
   Web of Science ®Google Scholar
• MuttilPKaurJKumarKYadavABSharmaRMisraAInhalable microparticles containing large payload of anti-tuberculosis drugsEur J Pharm Sci200732214015017681458
   PubMed Web of Science ®Google Scholar
• DonomaeICapreomycin in the treatment of pulmonary tuberculosisAnn N Y Acad Sci19661352101110384957083
   PubMed Web of Science ®Google Scholar
• GarfieldJWJonesJMCohenNLDalyJFMcClementJHThe auditory, vestibular and renal effects of capreomycin in humansAnn N Y Acad Sci19661352103910465296040
   PubMed Web of Science ®Google Scholar
• BrownJDooleyDBackerHDrug-Resistant Tuberculosis: A Survival Guide for Clinicians1st edSan Francisco, CATuberculosis Reference Centre, California Department of Health Servicesand Francis J Curry National Tuberculosis Centre2004
   Google Scholar
• O’HaraPHickeyAJRespirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterizationPharm Res200017895596111028941
   PubMed Web of Science ®Google Scholar
• SuarezSO’HaraPKazantsevaMAirways delivery of rifampicin microparticles for the treatment of tuberculosisJ Antimicrob Chemother200148343143411533012
   PubMed Web of Science ®Google Scholar
• SuarezSO’HaraPKazantsevaMRespirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease modelPharm Res20011891315131911683246
   PubMed Web of Science ®Google Scholar
• EdwardsDAHanesJCaponettiGLarge porous particles for pulmonary drug deliveryScience19972765320186818719188534
   PubMed Web of Science ®Google Scholar
• Garcia-ContrerasLHickeyAJPharmacokinetics of aerosolized rifampicin in the guinea pigDalbyRNByronPRPeartJFarrSJRespiratory Drug Delivery VIII2Raleigh, NCDavis Horwood International Publishing2002699702
   Google Scholar
• Garcia-ContrerasLFiegelJTelkoMJInhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig modelAntimicrob Agents Chemother20075182830283617517845
   PubMed Web of Science ®Google Scholar
• MizoeTOzekiTOkadaHApplication of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticlesAAPS Pharm Sci Tech200893755761
   PubMed Web of Science ®Google Scholar
• SharmaRSaxenaDDwivediAKMisraAInhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosisPharm Res200118101405141011697465
   PubMed Web of Science ®Google Scholar
• KawashimaYSeriganoTHinoTYamamotoHTakeuchiHSurface-modified antiasthmatic dry powder aerosols inhaled intratracheally reduce the pharmacologically effective dosePharm Res19981511175317599833999
   PubMed Web of Science ®Google Scholar
• MalcolmsonRJEmbletonJKDry powder formulations for pulmonary deliveryPharm Sci Technol Today19981394398
   Google Scholar
• O’BrienRJThe treatment of tuberculosisReichmanLBHershfieldESTuberculosis: A Comprehensive International ApproachNew York, NYMarcel Dekker1993120
   Google Scholar
• SotoEKimYSLeeJKornfeldHOstroffGGlucan particle encapsulated rifampicin for targeted delivery to macrophagesPolymers201024681689
   Web of Science ®Google Scholar
• AoudiMTeszGJNicoloroSMOrally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammationNature20094581180118419407801
   PubMed Web of Science ®Google Scholar
• SotoEROstroffGRCharacterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA deliveryBioconjug Chem200819484084818376856
   PubMed Web of Science ®Google Scholar
• LawtonJWZein: a history of processing and useCereal Chemistry2002791118
   Web of Science ®Google Scholar
• BenitaSMicroencapsulation: Methods and Industrial ApplicationsNew York, NYMarcel Dekkar1996
   Google Scholar
• KimBKHwangSJParkJBParkHJPreparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation methodJ Microencapsul200219681182212569029
   PubMed Web of Science ®Google Scholar
• MomanyFASessaDJLawtonJWSellingGWHamakerSAWillettJLStructural characterization of alpha-zeinJ Agric Food Chem200654254354716417318
   PubMed Web of Science ®Google Scholar
• MehtaSKKaurGVermaAFabrication of plant protein microspheres for encapsulation, stabilization and in vitro release of multiple anti-tuberculosis drugsColloids Surf A Physicochem Eng Asp20113751–3219230
   Web of Science ®Google Scholar
• WardAGThe Science and Technology of GelatinNew York, NYAcademic Press1977
   Google Scholar
• KaurAJainSTiwaryAKMannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluationActa Pharm2008581617418337208
   PubMed Web of Science ®Google Scholar
• CoesterCJLangerKvan BriesenHKreuterJGelatin nanoparticles by two step desolvation – a new preparation method, surface modifications and cell uptakeJ Microencapsul200017218719310738694
   PubMed Web of Science ®Google Scholar
• VermaAKSachinKSaxenaABohidarHBRelease kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor-cycloheximide, for possible therapeutic applicationsCurr Pharm Biotechnol20056212113015853691
   PubMed Web of Science ®Google Scholar
• SaraogiGKGuptaPGuptaUDJainNKAgrawalGPGelatin nanocarriers as potential vectors for effective management of tuberculosisInt J Pharm20103851–214314919819315
   PubMed Web of Science ®Google Scholar
• TabataYIkadaYEffect of the size and surface charge of polymer microspheres on their phagocytosis by macrophageBiomaterials1988943563623214660
   PubMed Web of Science ®Google Scholar
• HuaSYangHWangWWangAControlled release of ofloxacin from chitosan-montmorillonite hydrogelAppl Clay Sci2010501112117
   Web of Science ®Google Scholar
• MohanambeLVasudevanSInclusion of poly-aromatic hydrocarbon (PAH) molecules in a functionalized layered double hydroxideJ Chem Sci20061181105115 Available from: http://www.ias.ac.in/chemsci/Pdf-Jan2006/105.pdfAccessed August 1, 2012
   Web of Science ®Google Scholar
• AkyuzSAkyuzTFT-IR and FT-Raman spectroscopic studies of adsorption of isoniazid by montmorillonite and saponiteVib Spectrosc2008482229232
   Web of Science ®Google Scholar
• HusseinMZAl AliSHZainalZHakimMNDevelopment of anti-proliferative nanohybrid compound with controlled release property using ellagic acid as the active agentInt J Nanomedicine201161373138321796241
   PubMed Web of Science ®Google Scholar
• HusseinAlAliSHAl-QubaisiMHusseinMZZainalZHakimMNPreparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell linesInt J Nanomedicine201163099311122163163
   PubMed Web of Science ®Google Scholar
• PanchagnulaRAgrawalSBiopharmaceutic and pharmacokinetic aspects of variable bioavailability of rifampicinInt J Pharm20042711–21415129967
   PubMed Web of Science ®Google Scholar
• MonkhouseDCLachJLUse of adsorbents in enhancement of drug dissolution IIJ Pharm Sci1972619143514914341625
   PubMed Web of Science ®Google Scholar
• BrindleyGWX-ray and electron diffraction data for sepioliteAm Mineral195944495500
   Web of Science ®Google Scholar
• ViçosaALGomesACSoaresBGParanhosCMEffect of sepiolite on the physical properties and swelling behavior of rifampicin-loaded nanocomposite hydrogelseXPRESS Polymer Letters20093518524
   Web of Science ®Google Scholar
• Ruiz-OsunaCG-CROsteoarticular caseating tuberculosis of the hip: presenting as severe articular destruction. A case reportActa Ortop Mex2008224254258 Spanish18979989
   PubMedGoogle Scholar
• ZhuMWangHLiuJA mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapyBiomaterials20113271986196521163519
   PubMed Web of Science ®Google Scholar
• Vallet RegíMBallasFArcosDMesoporous materials for drug deliveryAngew Chem Int Engl2007464075487558
   Web of Science ®Google Scholar
• MohanambeLVasudevanSOrientational dynamics of anthracene in a cyclodextrin functionalized layered solidJ Phys Chem B200510924118651186916852459
   PubMed Web of Science ®Google Scholar
• Global Protein Products, IncZein: a natural biopolymer from a renewable resource [web page on the Internet]Fairfield, MEGlobal Protein Products, Inc2011 Available from: http://www.globalprotein.com/zein.htmlAccessed August 1, 2012
   Google Scholar
• BenitaSMicroencapsulation: Methods and Industrial ApplicationsMarcel DekkarNew York1996
   Google Scholar
• JoshiGhanshyam VKevadiyaBhavesh DPatelHasmukh ABajajHari CJasraRaksh VMontmorillonite as a drug delivery system: Intercalation and in vitro release of timolol maleateInternational Journal of Pharmaceutics2009374535719446759
   PubMed Web of Science ®Google Scholar
• World Health OrganizationTreatment of tuberculosis; Guidelines for national programmeWHO/CDS/TB2003
   Google Scholar